UNSPSC 51431704: Diltiazem

This classification denotes a calcium channel blocker with the molecular formula C22H26N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EE92BBP03H, chemically known as 3-acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one but generally known as diltiazem, which bears US NIH Compound Identifier 3076. European Medicines Agency schedules Diltiazem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07148MIG.

UNSPSC 51431704 Diltiazem is a Commodity code covering pharmaceutical supply to state and local emergency medical services and public health agencies. State and local procurement activity under this code centers on the acquisition of diltiazem vials and related advanced life support medications for fire rescue departments, emergency services, and hospital systems. The source shows municipal purchasing offices soliciting sealed bids for medication supply contracts that bundle diltiazem alongside other cardiac and emergency pharmaceuticals, with quantities typically ranging from dozens to thousands of units depending on the jurisdiction's operational needs. Issuing bodies are primarily city purchasing departments acting on behalf of municipal fire rescue and emergency medical services.

The City of Tampa's Purchasing Department posted an IFB (Solicitation No. 26P00188) on April 24, 2026, for Advanced Life Support Medications to serve Tampa Fire Rescue in Hillsborough County, Florida, with a sealed-bid response deadline of April 8, 2026, and an estimated contract value of $40,000. The bid included 1,020 units of diltiazem 25mg vials alongside labetalol, epinephrine, and adenosine, with a one-year contract term renewable for two additional one-year periods plus unilateral extension options for up to three 30-day periods. The solicitation carried a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount and required comprehensive accessibility documentation per WCAG 2.2 Level AA and Section 508 standards, along with OSHA-compliant Safety Data Sheets for all medications. The source provides only this single recent opportunity; geographic activity is limited to Florida based on available data.